WS Audiology (PRIVATE.WSAUDIO)

Overall impact
A (87)

Commentary

WS Audiology is a leader for overall positive impact. With an 'A' rating of 87.2 for overall impact (98th percentile compared to all companies), WS Audiology ranks 6th out of 196 industry peers, behind Sysmex, Modular Medical, WS Audiology and 4 others, and ahead of LifeScan, Fluoropharma Medical, Treace Medical Concepts and 185 others. On top material causes for WS Audiology's industry (Health Care Equipment & Supplies), WS Audiology performs well in Improved Mental Health (95.3 score), Racial Justice and Civil Rights (95.1), Improved Mental Health (95.3) and 61 other causes where it received an 'A' score and performs poorly in Reduced Green House Gas Emissions (38.5 score), Reduced Green House Gas Emissions (38.5) and Reduced Green House Gas Emissions (38.5).
Impact
Cause PRIVATE.WSAUDIO
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2019
Employees
12,500
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Denmark
Share classes
PRIVATE.WSAUDIO
TEMP.8637acd4
Description
Developer and manufacturer of leading-edge hearing aids designed for better hearing and understanding. The company's product spectrum covers the full range of hearing aids and accessories across all price categories and is sold via several brands. This diversity in offerings enables patients suffering from hearing loss to live an improved life.
Material causes
Ethos considers the following causes material for WS Audiology, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.